
Neurobit is building a Universal health analytics platform using sleep as a biomarker across age, gender and race.
Neurobit uses physiological signals collected during sleep to uncover these patterns. Using sleep as a biomarker, Neurobit is building a Universal health analytics platform with their state-of-the-art AI models, trained on over a trillion data points of multi-channel physiological data to operate across devices, signals and disease conditions.
2022
Jan | Strategic Partnership
Strategically partnered with over 150 universities and research clinics around the world with access to one of the worlds largest health dataset enabling neurobit to build state-of-art 20+ AI models.
Jun | Stepped into New Market
Expanded globally with HQ in New York,Times Square and operating units in Singapore and Bangalore.
2023
Jan | Product Launch
Completed 4 Clinical trials in Singapore and US with a major publication in high impact peer-reviewed Journal.
May | Stepped into New Market
Neurobit Digital Health Lab Launched to allow AI-enabled Self-health assessment for every Indian.
Oct | Strategic Partnership
Successfully integrated into the Ayushman Bharat Digital Mission (ABDM) ecosystem .
B2B
Hospital and Clinics focussed on Pulmonology, Cardiology and Neurology.
Client Segment
:
BioTech/BioPharmaceutical,
HealthTech / MedTech / Healthcare,
Software,
Insurance
Target Companies
:
Medium Enterprise,
Large Enterprise
Target Geography
:
Chemicea Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical company specializing in the synthesis and supply of high-purity impurity reference standards, including process impurities, degradation products, and nitrosamines. Founded in 2016 and headquartered in Navi Mumbai, the company supports global pharmaceutical and research organizations with products and services for drug development, quality control, and regulatory compliance.
Frequently Asked Questions
Chemicea Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical company specializing in the synthesis and supply of high-purity impurity reference standards, including process impurities, degradation products, and nitrosamines. Founded in 2016 and headquartered in Navi Mumbai, the company supports global pharmaceutical and research organizations with products and services for drug development, quality control, and regulatory compliance.